Company Overview and News

61
Alcoa: Strong Operating Momentum, Attractive Relative Value

2018-06-22 seekingalpha
According to our metrics, Alcoa is experiencing strong operating momentum, trades at an outstanding relative value, and is experiencing significantly positive consensus estimate momentum.
AAI DB ARNC.PR AA.PR ARNC.PRB AA.PRB KALU ARNC AA

30
ARNC / Arconic Inc. FORM SD

2018-05-30 sec.gov
United States Securities and Exchange Commission
ARNC

32
Why Is Arconic (ARNC) Down 17.1% Since its Last Earnings Report?

2018-05-30 zacks
A month has gone by since the last earnings report for Arconic Inc. (ARNC - Free Report) . Shares have lost about 17.1% in that time frame.
ARNC.PR ARNC.PRB ARNC MPWR MPC

54
Arconic: Not Delivering Upon Its Promises

2018-05-29 seekingalpha
Arconic has continued to lag despite growing end markets, a strong economy and involvement of activist investor Elliott.
ARNC AA

29
ARNC / Arconic Inc. FORM 8-K (Current Report)

2018-05-22 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
ARNC

32
Arconic: Down But Not Out

2018-05-21 seekingalpha
Aluminium pricing is being affected by tariffs, which will have an unknown duration, but should end eventually.
ARNC.PR ARNC.PRB ARNC

31
What Falling Estimates & Price Mean for Arconic (ARNC)

2018-05-15 zacks
Similar to wise buying decisions, exiting certain underperformers at the right time helps maximize portfolio returns. Selling off losers can be difficult, but if both the share price and estimates are falling, it could be time to get rid of the security before more losses hit your portfolio.
ARNC.PR ARNC.PRB ARNC

32
What Falling Estimates & Price Mean for Arconic (ARNC)

2018-05-10 zacks
Similar to wise buying decisions, exiting certain underperformers at the right time helps maximize portfolio returns. Selling off losers can be difficult, but if both the share price and estimates are falling, it could be time to get rid of the security before more losses hit your portfolio.
STLD FBC ARNC.PR ARNC.PRB ARNC ELLI

113
New Strong Sell Stocks for May 3rd

2018-05-03 zacks
ABM Industries Incorporated (ABM - Free Report) is a provider of integrated facility solutions across the globe. The Zacks Consensus Estimate for its current year earnings has been revised 4.9% downward over the last 60 days.
AIZ ARNC.PR AIMC CGNX ARNC.PRB ABM AMH P ARNC

362
Stocks Are Facing The Burden Of Unrealistic Expectations - Cramer's Mad Money (5/1/18)

2018-05-02 seekingalpha
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Tuesday, May 1.
F GE GEC CAT UTX ARNC MPC ANDV CMI EOG SWKS V FDC AAPL GNE SWN AGCO

30
354
Stock Market News For May 1, 2018

2018-05-01 zacks
U.S. stock markets ended in negative territory on Monday as a broad-based decline pushed all three major indexes in red. Slide into the healthcare and industrial stocks more than offset gains from several merger and acquisitions (M&A) except a telecom mega deal. Moreover, strong first quarter earnings results also failed to uplift investor’s sentiment.
LRCX ARNC.PR CAT PLD.PRS DCT PLD.PRR MS.PRE ARNC.PRB MS.PRF PLD.PRG MS.PRG PLD.PRF MPC MS.PRA PLDGP JSNSF AAPL CELG AKS MS CELGZ CATR TMUSP JSAIY TMUS ARNC S PLD MS.PRI MS.PRK

126
Top Analyst Upgrades and Downgrades: AK Steel, Arconic, Facebook, Inogen, Roku, Sprint, SteadyMed and More

2018-05-01 247wallst
Stocks closed lower on Monday as profit-taking prevailed over positive earnings and good economic news, and the market indices were looking for direction on Tuesday. Investors have noticed that selling pressure around profit-taking and volatility fears have overcome the dominance of the “buy the sell-offs” mentality. The bull market is also over nine years old and has run into a tired spell. Now investors are wondering how to position their assets and investments for the rest of 2018 and beyond.
FB TXRH VAC ARNC.PR KMI.WS STDY DCT IEX ARNC.PRB MPC INGN KMI.PRA KMI AKS KMR CVB PKI MOG.A TTWO ARNC MOG.B S ROKU TRI KMRFZ CLUB

110
Wall Street slides as healthcare drags

2018-05-01 thehindubusinessline
Wall Street fell on Monday as healthcare stocks slid and investors worried about rising costs for companies as oil prices rose, although the major indexes eked out a gain in April to snap a two-month losing streak.
CELGZ TMUSP ARNC.PR TMUS MS.PRE ARNC.PRB MS.PRF MS.PRG ARNC MS.PRA MS.PRI S MS.PRK CELG MS

Related Articles

CASC: Cascadian Therapeutics Analysis and Research Report

2018-06-22 - Asif

Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...

BAC: Bank of America Corp. Analysis and Research Report

2018-06-22 - Asif

Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

2018-06-18 - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

Silicon Investor Message Boards

This table lists all message boards related to ARNC / Arconic Inc. on message board site Silicon Investor.

LRCM - LearnCom
CUSIP: 013817101